Dorothee Selimoglu-Buet
Overview
Explore the profile of Dorothee Selimoglu-Buet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Solary E, Wagner-Ballon O, Selimoglu-Buet D
Best Pract Res Clin Haematol
. 2020 May;
33(2):101134.
PMID: 32460985
In the last version of the WHO classification of myeloid malignancies, flow cytometry and molecular investigation are listed as potentially useful, yet non-essential diagnostic tools in hard-to-recognize chronic myelomonocytic leukemias...
12.
Tarfi S, Badaoui B, Freynet N, Morabito M, Lafosse J, Toma A, et al.
Haematologica
. 2019 Aug;
105(4):e147-e152.
PMID: 31413091
No abstract available.
13.
Selimoglu-Buet D, Riviere J, Ghamlouch H, Bencheikh L, Lacout C, Morabito M, et al.
Nat Commun
. 2018 Dec;
9(1):5455.
PMID: 30575719
Non-classical monocyte subsets may derive from classical monocyte differentiation and the proportion of each subset is tightly controlled. Deregulation of this repartition is observed in diverse human diseases, including chronic...
14.
Tarfi S, Harrivel V, Dumezy F, Guy J, Roussel M, Mimoun A, et al.
Blood Cancer J
. 2018 Nov;
8(11):114.
PMID: 30429467
Peripheral blood monocytes include three subsets defined by CD14 and CD16 surface markers. An increase in the CD14CD16 classical monocyte fraction ≥ 94% of the total monocytes was proposed to...
15.
Anderson M, Chaze T, Coic Y, Injarabian L, Jonsson F, Lombion N, et al.
Cell Chem Biol
. 2018 Feb;
25(4):483-493.e9.
PMID: 29478905
Neutrophils represent the most abundant immune cells recruited to inflamed tissues. A lack of dedicated tools has hampered their detection and study. We show that a synthesized peptide, MUB, binds...
16.
Ricard L, Abisror N, Droin N, Selimoglu-Buet D, Martin A, Soussan M, et al.
Leuk Lymphoma
. 2018 Jan;
59(10):2503-2505.
PMID: 29368535
No abstract available.
17.
Zhang Y, He L, Selimoglu-Buet D, Jego C, Morabito M, Willekens C, et al.
Blood Adv
. 2018 Jan;
1(14):972-979.
PMID: 29296739
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder that typically associates with mutations in epigenetic, splicing, and signaling genes. Genetically modified mouse models only partially recapitulate the...
18.
Sakr R, Renneville A, Saada V, Cotteret S, Martin J, Droin N, et al.
Leuk Lymphoma
. 2017 Nov;
59(7):1742-1745.
PMID: 29115897
No abstract available.
19.
Vazquez R, Roussel M, Badaoui B, Freynet N, Tarfi S, Solary E, et al.
Cytometry B Clin Cytom
. 2017 Nov;
94(5):658-661.
PMID: 29108126
Background: Accumulation of classical monocytes CD14 CD16 (also called MO1) ≥ 94% can accurately distinguish chronic myelomonocytic leukemia (CMML) from reactive monocytosis. The HematoFlow™ solution, able to quantify CD16 negative...
20.
Selimoglu-Buet D, Badaoui B, Benayoun E, Toma A, Fenaux P, Quesnel B, et al.
Blood
. 2017 Jun;
130(6):832-835.
PMID: 28611023
No abstract available.